CRNX - Crinetics Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$85.83
DETAILS
HIGH:
$105.00
LOW:
$67.00
MEDIAN:
$85.50
CONSENSUS:
$85.83
UPSIDE:
133.23%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 86.0% |
| EBIT Margin | -6714.8% |
| EBITDA Margin | -6664.2% |
| Operating Margin | -6714.8% |
| Pretax Margin | -6043.9% |
| Cont. Ops Margin | -6046.2% |
| Net Margin | -6046.2% |
| Bottom Line Margin | -6046.2% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 12.32 |
| Quick Ratio | 12.30 |
| Solvency Ratio | -3.217 |
| Cash Ratio | 1.19 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-9.41
Peers avg: 19.3
|
| PEG Ratio | -0.28 |
| Forward PEG | -0.28 |
| Price/Book | 4.41 |
| Price/Sales | 568.91 |
| Price/FCF | -11.41 |
| Price/Op Cash Flow | -11.59 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0427 |
| Debt/Equity | 0.0489 |
| Debt/Capital | 0.0466 |
| Long-Term Debt/Capital | 0.0000 |
| Financial Leverage | 1.14 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.01 |
| Operating Cash Flow Ratio | -4.442 |
| Operating Cash Flow/Sales | -4910.6% |
| Free Cash Flow/Operating Cash Flow | 101.5% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -79.07 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | -58.24 |
| Operating Cash Flow Coverage | -7.79 |
| Capital Expenditure Coverage | -65.59 |
| Dividend + Capital Expenditure Coverage | -65.59 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.08 |
| EPS | -4.947 |
| Debt/Share | 0.5161 |
| Cash/Share | 10.93 |
| Book Value/Share | 10.55 |
| Tangible BV/Share | 10.55 |
| Equity/Share | 10.55 |
| Operating Cash Flow/Share | -4.018 |
| Capital Expenditure/Share | 0.061 |
| FCF/Share | -4.079 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 0.900 |
| Price/Fair Value | 4.41 |
| Debt/Market Cap | 0.0015 |
| Effective Tax Rate | -0.0% |
| Enterprise Value Multiple | -8.43 |